WebApr 29, 2024 · Introduction. Pancreatic squamous cell carcinoma (SCC) is a rare primary pancreatic malignancy, comprising 0.5–5% of all exocrine pancreatic neoplasms. It is … WebOct 4, 2024 · Because cisplatin is a long-standing chemo drug available in generic form, adding the drug should not dramatically increase the cost of cancer treatment, Von Hoff …
Pancreatic Cancer Treatment Protocols - Medscape
WebApr 12, 2024 · The patient was started on gemcitabine, cisplatin, and nanoparticle albumin-bound paclitaxel (nab-paclitaxel). After 3 months of chemotherapy, the patient's AFP increased to 43.8 ng/ml and her CA 19-9 increased to 21.4 U/ml. ... Nab-paclitaxel may enhance the delivery of gemcitabine by depleting the surrounding stroma associated with … Web2 days ago · Overactive gene NAE1 lifts the cell division brake. To get to the bottom of the causes of cisplatin resistance in testicular cancer, the Bonn research team used CRISPR gene scissors. maria gemma piriz chacon
Concurrent chemoradiotherapy with gemcitabine and cisplatin for ...
WebFeb 10, 2024 · As first-line treatment of patients with pancreatic ductal adenocarcinoma and a germline BRCA/PALB2 mutation, cisplatin plus gemcitabine yielded high response rates and encouraging survival, establishing this doublet as a standard approach in this subset of patients, according to Eileen M. O’Reilly, MD, of Memorial Sloan Kettering … WebSep 20, 2024 · First-line treatment recommendations for advanced metastatic pancreatic cancer (stage IV): Paclitaxel protein bound 125 mg/m 2 plus gemcitabine 1000 mg/m 2 IV over 30-40 min on days 1, 8, and 15... WebA 60-year-old Caucasian female presented with stage IIA (T2N0M0) estrogen- and progesterone-negative and HER2-positive breast cancer. She was started on an adjuvant chemotherapy regimen of docetaxel, carboplatin, and trastuzumab (TCH). She tolerated the first two cycles of the TCH regimen well. mariage nea